The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients
Clinical trial NCT07739160 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07739160
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2027-04-30
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.